These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11504094)

  • 1. Higher relative biological efficiency of alpha-particles: in vitro veritas, in vivo vanitas?
    Behr TM
    Eur J Nucl Med; 2001 Jul; 28(7):939-40. PubMed ID: 11504094
    [No Abstract]   [Full Text] [Related]  

  • 2. Higher relative biological efficiency of alpha-particles: in vitro veritas, in vitro vanitas?
    Behr TM; Béhé M; Jungclas H; Jungclas H; Becker W; Sgouros G
    Eur J Nucl Med; 2001 Sep; 28(9):1435-6. PubMed ID: 11585306
    [No Abstract]   [Full Text] [Related]  

  • 3. The magic-bullet: moving the concept towards reality – part II.
    Elgqvist J
    Curr Radiopharm; 2011 Oct; 4(4):281-2. PubMed ID: 22202150
    [No Abstract]   [Full Text] [Related]  

  • 4. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor therapy with targeted atomic nanogenerators.
    McDevitt MR; Ma D; Lai LT; Simon J; Borchardt P; Frank RK; Wu K; Pellegrini V; Curcio MJ; Miederer M; Bander NH; Scheinberg DA
    Science; 2001 Nov; 294(5546):1537-40. PubMed ID: 11711678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative therapeutic efficacy of (125)I- and (131)I-labeled monoclonal antibody A33 in a human colon cancer xenograft.
    Barendswaard EC; Humm JL; O'Donoghue JA; Sgouros G; Finn RD; Scott AM; Larson SM; Welt S
    J Nucl Med; 2001 Aug; 42(8):1251-6. PubMed ID: 11483688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Alpha-radioimmunotherapy: a review of recent developments].
    Supiot S; Thillays F; Rio E; Mahé MA; Barbet FJ; Kraeber-Bodéré F; Chérel M
    Cancer Radiother; 2007 Sep; 11(5):252-9. PubMed ID: 17604673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer therapy with Auger electrons: are we almost there?
    Kassis AI
    J Nucl Med; 2003 Sep; 44(9):1479-81. PubMed ID: 12960195
    [No Abstract]   [Full Text] [Related]  

  • 9. Relative biological effectiveness of high linear energy transfer α-particles for the induction of DNA-double-strand breaks, chromosome aberrations and reproductive cell death in SW-1573 lung tumour cells.
    Franken NA; Hovingh S; Ten Cate R; Krawczyk P; Stap J; Hoebe R; Aten J; Barendsen GW
    Oncol Rep; 2012 Mar; 27(3):769-74. PubMed ID: 22200791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential and pitfalls of therapy with alpha-particles.
    Welch MJ
    J Nucl Med; 2005 Aug; 46(8):1254-5. PubMed ID: 16085579
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeted alpha-particle therapy of microscopic disease: Providing a further rationale for clinical investigation.
    Zalutsky MR
    J Nucl Med; 2006 Aug; 47(8):1238-40. PubMed ID: 16882999
    [No Abstract]   [Full Text] [Related]  

  • 12. The biological effectiveness of radon-progeny alpha particles. II. Oncogenic transformation as a function of linear energy transfer.
    Miller RC; Marino SA; Brenner DJ; Martin SG; Richards M; Randers-Pehrson G; Hall EJ
    Radiat Res; 1995 Apr; 142(1):54-60. PubMed ID: 7899559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of Cell Killing Response from Low Linear Energy Transfer (LET) Radiation Originating from (177)Lu Radioimmunotherapy Targeting Disseminated Intraperitoneal Tumor Xenografts.
    Yong KJ; Milenic DE; Baidoo KE; Brechbiel MW
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27196891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted Radiotherapy with Alpha-Particle Emitting Radionuclides Seminar, November 18, 2004, Cracow, Poland.
    Zalutsky MR; Petelenz B
    Nucl Med Rev Cent East Eur; 2004; 7(2):195. PubMed ID: 15968616
    [No Abstract]   [Full Text] [Related]  

  • 15. Current status and perspectives in alpha radioimmunotherapy.
    Chérel M; Davodeau F; Kraeber-Bodéré F; Chatal JF
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):322-9. PubMed ID: 17043629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral 224Ra-loaded wires spread alpha-emitters inside solid human tumors in athymic mice achieving tumor control.
    Cooks T; Tal M; Raab S; Efrati M; Reitkopf S; Lazarov E; Etzyoni R; Schmidt M; Arazi L; Kelson I; Keisari Y
    Anticancer Res; 2012 Dec; 32(12):5315-21. PubMed ID: 23225432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the secondary charged-particle spectrum on cellular response to fast neutrons.
    Bewley DK; McNally NJ; Page BC
    Radiat Res; 1974 Apr; 58(1):111-21. PubMed ID: 10876612
    [No Abstract]   [Full Text] [Related]  

  • 18. RBE-LET relationship for proton and alpha irradiations studied with a nanodosimetric approach.
    Villagrasa C; Dos Santos M; Bianco D; Gruel G; Barquinero JF; Clairand I
    Radiat Prot Dosimetry; 2014 Oct; 161(1-4):449-53. PubMed ID: 24759916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative biological effectiveness of alpha particles at radon exposure.
    Zhukovsky M; Bastrikova N; Vasilyev A
    Radiat Prot Dosimetry; 2015 Jun; 164(4):467-70. PubMed ID: 25979745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivo.
    Bäck T; Andersson H; Divgi CR; Hultborn R; Jensen H; Lindegren S; Palm S; Jacobsson L
    J Nucl Med; 2005 Dec; 46(12):2061-7. PubMed ID: 16330571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.